Is AOD-9604 Legal? Regulation Status & Availability

Global Legal Status: What You Need to Know

AOD-9604's legal status varies significantly by country. It is not FDA-approved in the United States, never completed clinical development for therapeutic approval, and exists in a regulatory gray area in most jurisdictions.

United States: AOD-9604 is not FDA-approved and is classified as a research chemical. It is legal to purchase from research supply vendors labeled "for research use only." However, using it for personal fat loss is off-label and not medically endorsed. The FDA does not actively enforce against research peptide possession for personal use (unlike illicit drugs), but clinical use without FDA approval is illegal. Therapeutic administration by healthcare providers would violate FDA regulations.

European Union: Status varies by member state. Some EU countries (UK post-Brexit, Germany, Netherlands) allow research chemical sales with "not for human consumption" disclaimers. Others have stricter regulations. Verify with your specific country's health authority before purchasing.

Canada: AOD-9604 is not Health Canada-approved. Research chemical sales exist in a legal gray area. Clinical use is not permitted without approval. Personal possession for research purposes is generally not prosecuted, but therapeutic use is not medically endorsed.

Australia: Unique status—AOD-9604 was approved by the Therapeutic Goods Administration (TGA) under the brand name Metabol for investigational use. However, development was discontinued, and it's not currently available through standard pharmaceutical channels. It exists as a research chemical in Australia similar to other countries.

Key caveat: Laws change rapidly. Always verify current legal status in your jurisdiction before purchasing or using AOD-9604. Consult a lawyer if uncertain about local regulations.

WADA Banned Status: Athletic and Competitive Implications

The World Anti-Doping Agency (WADA) lists AOD-9604 as a prohibited substance in sport, classified under "Hormone and Metabolic Modulators." This has critical implications for athletes.

WADA-tested sports include: Olympic athletics, professional cycling, swimming, rowing, weight lifting, most professional team sports (NFL, NBA, soccer leagues in many countries), MMA/combat sports, and many others. Comprehensive list at wada-ama.org.

Consequences of testing positive: Testing positive for AOD-9604 in WADA-tested sports results in disqualification from competition, bans ranging from 1-4 years depending on sport and circumstances, loss of medals/titles, and potential criminal charges in some jurisdictions. The consequences are severe and permanent to athletic careers.

Detection window: AOD-9604 clears from circulation in 90 minutes due to its short half-life. However, metabolites may be detectable in urine for 24-48 hours post-injection via sophisticated testing. WADA testing has evolved; assume any use in the weeks before competition carries detectable risk.

Non-WADA sports: Body building competitions, CrossFit competitions (which don't use WADA testing), and many recreational sports don't test for AOD-9604. Athletes in these sports can use AOD-9604 legally (assuming it's legal in their jurisdiction), though sport-specific organizations may have separate rules. Always verify with your sport's governing body.

Practical clarity: If you're a competitive athlete in any WADA-tested sport, AOD-9604 is off-limits. The legal, professional, and reputational consequences are not worth the modest fat-loss benefit. Non-tested sports are more permissive.

FDA Approval History and Clinical Development Timeline

AOD-9604 underwent clinical trials but never achieved FDA approval. Understanding this history clarifies its regulatory status.

1990s-early 2000s: Monash University developed AOD-9604 and conducted Phase 1 and Phase 2 clinical trials in approximately 900 overweight human participants. Results demonstrated safety and efficacy. The compound showed promise for weight management and improved body composition.

Early 2000s: Development was licensed to Australian pharmaceutical company Metabol, which pursued commercialization. The TGA in Australia approved it under the brand name Metabol, marking the only governmental approval of AOD-9604 for investigational therapeutic use.

2000s-2010s: Metabol applied for FDA approval in the United States. However, the FDA requested additional clinical data, particularly regarding long-term safety and efficacy in larger populations. Development was discontinued, likely due to commercial viability concerns (development costs, competitive landscape with emerging GLP-1 agonists, regulatory burden).

Post-2010: AOD-9604 has not been pursued for FDA approval. It remains available as a research chemical from research supply vendors, used primarily by the peptide research community. No major pharmaceutical company has revived the development program.

Current status: AOD-9604 will likely never be FDA-approved. The development window has closed—GLP-1 agonists (semaglutide, tirzepatide) have captured the pharmaceutical fat-loss market with superior efficacy, and AOD-9604 lacks the commercial incentive for modern approval pathways.

Purchasing Considerations and Vendor Vetting

AOD-9604 is available from research chemical suppliers, but purchasing requires caution regarding legality, quality, and vendor reliability.

Legality of purchase: In most countries (US, Canada, EU, Australia), purchasing AOD-9604 for research purposes is legal if the vendor labels it "for research use only" and you don't claim therapeutic intent. Stating "I'm buying this for my weight loss" to a vendor or law enforcement would be incriminating. Research vendors operate under the assumption that customers are chemists, researchers, or educational users—not patients seeking therapy.

Vendor vetting: Quality varies dramatically among research suppliers. Reputable vendors (those with established histories, published reviews, transparent testing protocols) are preferable but more expensive. Red flags: unsecured websites, no contact information, prices significantly lower than competitors (potential counterfeit), no Certificate of Analysis (CoA), zero reviews or reviews that appear fraudulent.

Quality assurance: Request a Certificate of Analysis (CoA) from the vendor before purchasing. This document, from an independent third-party lab, confirms the peptide's purity and concentration. A legitimate AOD-9604 product should be >95% pure, accurately dosed, and free of endotoxins. Without a CoA, you're purchasing blind.

Counterfeiting risk: Black-market and unreliable vendors sometimes sell counterfeit or impure peptides. Products may contain significantly less AOD-9604 than labeled, no AOD-9604 at all, or contaminated ingredients. This not only wastes money but poses safety risks (injecting contaminated material can cause infection).

Practical recommendation: Purchase only from established research chemical vendors with transparent testing, published reviews, and customer service responsiveness. Expect to pay $150-400 per vial for legitimate AOD-9604. Significantly cheaper offerings warrant skepticism.

Medical and Legal Use: Physician Oversight

AOD-9604 is not a standard medical therapy in any country. Healthcare providers cannot legally prescribe it for fat loss or weight management in the United States and most other jurisdictions.

United States: Physicians are not permitted to prescribe AOD-9604 for any indication (it's not FDA-approved). Some functional medicine or anti-aging clinics may operate in gray areas, providing AOD-9604 "off-label" or under the guise of "research" or "personalized protocols," but this is legally questionable and not standard medical practice. Any physician doing this assumes legal risk.

Informed consent and liability: If a physician provides AOD-9604, they should obtain informed consent documenting that it's unapproved, experimental, and carries unknown long-term risks. However, many physicians providing AOD-9604 (if any exist) may not follow strict informed consent protocols, exposing patients to medical malpractice risk if complications occur.

Self-administration: Most users of AOD-9604 self-administer without physician supervision. This removes healthcare provider liability but places full responsibility on the user for outcomes. If adverse events occur (infection, systemic reaction), the user must manage medical care without clear guidance, as most physicians are unfamiliar with AOD-9604.

Recommendation: If using AOD-9604, obtain baseline bloodwork (lipid panel, glucose, liver function, kidney function) before starting. Repeat labs after 8-12 weeks to ensure metabolic health is preserved. Discuss use with your primary care physician (though most will discourage it) so they can monitor you. Do not use if pregnant, breastfeeding, or have significant medical conditions (diabetes, cardiovascular disease, liver/kidney dysfunction).

Sports Anti-Doping Regulations and Athlete Implications

AOD-9604's status in competitive sports is unambiguous: it's banned. Understanding the anti-doping landscape helps athletes make informed decisions and avoid career-ending consequences.

WADA (World Anti-Doping Agency) classification: AOD-9604 is listed in WADA's Prohibited List under "Hormone and Metabolic Modulators" (section S4). This classification covers peptides and hormones that influence metabolic processes or body composition. The ban applies to all WADA-tested sports: Olympic athletics, swimming, cycling, weight lifting, most professional team sports (NFL, NBA, MLB, soccer, rugby), MMA/combat sports, and many others. The comprehensive list is maintained at wada-ama.org.

Testing protocols and detection: WADA testing has evolved significantly. AOD-9604's 15-20 minute half-life makes immediate serum detection difficult (the peptide clears rapidly), but metabolites persist in urine for 24-48 hours. Modern tests employ peptide-specific mass spectrometry that can detect AOD-9604 metabolites days after injection. Assumption: any use within 2 weeks of competition carries detectable risk. The testing landscape continues evolving; assume AOD-9604 is detectable if specifically tested.

Sanctions and athlete consequences: Testing positive for AOD-9604 in WADA sport results in: disqualification from current competition, mandatory ban from future competition (typically 2-4 years, sometimes permanent), forfeiture of medals and titles (retrospective, if positive tests are later discovered), and in some jurisdictions, criminal charges. The career consequences are catastrophic and permanent. A single positive test can end an athletic career, destroy earnings, and create permanent public notoriety.

Non-WADA sports and governing bodies: Body building competitions, CrossFit competitions (though CrossFit is moving toward WADA testing), and many recreational sports don't systematically test for AOD-9604 or other banned peptides. However, individual sport organizations may have separate rules. Always verify with your specific sport's governing body before using AOD-9604. Some organizations maintain independent banned substance lists that may differ from WADA's.

Practical guidance for athletes: If you compete in any WADA-tested sport, AOD-9604 is categorically off-limits. The risk-benefit calculation is unfavorable: modest fat-loss benefit versus potential career-ending consequences. Non-WADA athletes should verify their sport's specific rules before using. The peptide community ethics also matter—doping undermines fair competition; consider whether enhancement aligns with your athletic values.

Future Regulatory Outlook: Will AOD-9604 Remain Available?

AOD-9604's availability as a research chemical is contingent on regulatory environments that may shift. Predicting future regulatory status requires analyzing regulatory trends and AOD-9604's unique position in the peptide landscape.

Current regulatory environment (2026): Research peptides exist in a permissive regulatory niche in most Western countries. The FDA, EMA, Health Canada, and other agencies focus enforcement on pharmaceutical drugs and scheduled controlled substances. Research chemicals labeled "for research use only" occupy a gray zone: technically unregulated for human use but tacitly tolerated as long as vendors don't make therapeutic claims. This permissiveness extends to AOD-9604.

Risk factors for future restriction: Several scenarios could restrict AOD-9604 availability: (1) Major adverse event linked to AOD-9604 in humans (unlikely given its safety profile, but if it occurred, regulators would respond). (2) Regulatory crackdown on research peptides broadly (possible if peptide misuse becomes widespread; some countries are already tightening rules). (3) Congressional action in the US to regulate research chemicals more strictly (periodically proposed but not yet enacted). (4) Olympics or international sports scandals involving peptide doping could trigger regulatory scrutiny (less likely to affect AOD-9604 specifically, but could have collateral effects).

Protective factors for continued availability: (1) AOD-9604 has an established safety record from 900+ human participants in clinical trials—regulatory bans typically follow documented harms, not hypothetical ones. (2) Limited black-market abuse (AOD-9604 is used by informed fitness/research communities, not street drugs). (3) Legitimate research interest from academic institutions (Monash, European universities continue publishing mechanistic studies). (4) Lack of pharmaceutical competition—no company is pushing for AOD-9604 restrictions because no one owns its patent and no one profits from its restriction. Contrast with semaglutide, where the manufacturers have incentive to restrict competing drugs.

Realistic outlook (2026-2035): AOD-9604 will likely remain available as a research chemical in most Western countries for the foreseeable future. Regulatory tightening is possible but not imminent. If planning long-term use, consider building a small 1-2 year supply (vials are stable indefinitely at room temperature) as insurance against future supply disruption. However, this is precautionary—no imminent ban is anticipated.

Trusted Research-Grade Sources

Below are the two vendors we recommend for research peptides — both publish independent third-party Certificates of Analysis (COAs) and ship internationally. Affiliate links: we earn a small commission at no extra cost to you (see Affiliate Disclosure).

Frequently Asked Questions